IL6 and COVID-19: A high level of serum IL-6 is an indicator of cytokine release syndrome (CRS), consistently reported by several studies on COVID-19 and associated with the severity of the disease, such that some authors consider IL-6 an irreplaceable marker of CRS [1,30].